BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mathews B, Thalody AA, Miraj SS, Kunhikatta V, Rao M, Saravu K. Adverse Effects of Fluoroquinolones: A Retrospective Cohort Study in a South Indian Tertiary Healthcare Facility. Antibiotics (Basel) 2019;8:E104. [PMID: 31357640 DOI: 10.3390/antibiotics8030104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bottalico L, Charitos IA, Potenza MA, Montagnani M, Santacroce L. The war against bacteria, from the past to present and beyond. Expert Rev Anti Infect Ther 2021;:1-26. [PMID: 34874223 DOI: 10.1080/14787210.2022.2013809] [Reference Citation Analysis]
2 . Leserbrief zum Artikel „Aus der Gutachtenpraxis: Tendinitis nach nicht indizierter Gabe eines Fluorchinolon-Antibiotikums bei akuter Rhinosinusitis – ein Behandlungsfehler“, LRO 08/2021. Laryngorhinootologie 2022;101:14-5. [PMID: 34963154 DOI: 10.1055/a-1684-5059] [Reference Citation Analysis]
3 Mixon MA, Dietrich S, Bushong B, Peksa GD, Rogoszewski R, Theiler A, Spears L, Werth J, Meister E, Martin MS. Urinary tract infection pocket card effect on preferred antimicrobial prescribing for cystitis among patients discharged from the emergency department. Am J Health Syst Pharm 2021;78:1417-25. [PMID: 33889933 DOI: 10.1093/ajhp/zxab175] [Reference Citation Analysis]
4 Saad NA, Elberry AA, Samy Matar H, Hussein RRS. Effect of ciprofloxacin vs levofloxacin on QTc-interval and dysglycemia in diabetic and non-diabetic patients. Int J Clin Pract 2021;75:e14072. [PMID: 33559294 DOI: 10.1111/ijcp.14072] [Reference Citation Analysis]
5 Mallhi TH, Alanazi AS, Khan YH, Alotaibi NH, Salman M, Alzarea AI, Khan S, Alruwaili NK, Alenazi AS, Alatawi AD, Iqbal Z, Butt MH, Iqbal MS. Assessment of Knowledge Regarding Safety Profile, Use, and Boxed Warnings of Fluoroquinolones Among Healthcare Professionals in Saudi Arabia: A Potential Implication for Drug Regulatory Authorities. Front Med 2022;9:816320. [DOI: 10.3389/fmed.2022.816320] [Reference Citation Analysis]
6 Jansåker F, Li X, Knudsen JD, Milos Nymberg V, Sundquist K. The Effect of Sociodemographic Factors, Parity and Cervical Cancer on Antibiotic Treatment for Uncomplicated Cystitis in Women: A Nationwide Cohort Study. Antibiotics (Basel) 2021;10:1389. [PMID: 34827326 DOI: 10.3390/antibiotics10111389] [Reference Citation Analysis]
7 Qureshi S, Resham S, Hashmi M, Naveed AB, Haq Z, Ali SA. A retrospective review on antibiotic use in acute watery diarrhea in children in a tertiary care hospital of Karachi, Pakistan. PLoS One 2021;16:e0253712. [PMID: 34264965 DOI: 10.1371/journal.pone.0253712] [Reference Citation Analysis]
8 Poyongo BP, Sangeda RZ. Pharmacists' Knowledge, Attitude and Practice Regarding the Dispensing of Antibiotics without Prescription in Tanzania: An Explorative Cross-Sectional Study. Pharmacy (Basel) 2020;8:E238. [PMID: 33322193 DOI: 10.3390/pharmacy8040238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Barbhuiya NH, Adak A. Determination of antimicrobial concentration and associated risk in water sources in West Bengal state of India. Environ Monit Assess 2021;193:77. [PMID: 33474619 DOI: 10.1007/s10661-020-08801-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Althaqafi A, Ali M, Alzahrani Y, Ming LC, Hussain Z. How Safe are Fluoroquinolones for Diabetic Patients? A Systematic Review of Dysglycemic and Neuropathic Effects of Fluoroquinolones. Ther Clin Risk Manag 2021;17:1083-90. [PMID: 34675522 DOI: 10.2147/TCRM.S284171] [Reference Citation Analysis]
11 Li X, Sundquist K, Jansåker F. Fluoroquinolones and Other Antibiotics Redeemed for Cystitis—A Swedish Nationwide Cohort Follow-Up Study (2006–2018). Antibiotics 2022;11:172. [DOI: 10.3390/antibiotics11020172] [Reference Citation Analysis]
12 Majalekar PP, Shirote PJ. Fluoroquinolones: Blessings Or Curses. Curr Drug Targets 2020;21:1354-70. [PMID: 32564750 DOI: 10.2174/1389450121666200621193355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Ullah A, Ahmad S, Ali N, Rahman SU, Hussain H, Alghamdi S, Almehmadi M, Dablool AS, Bannunah AM, Bukhari SH, Almarshad F. Insulinotropic Potential of Moxifloxacin and Gemifloxacin: An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial. Antibiotics 2022;11:148. [DOI: 10.3390/antibiotics11020148] [Reference Citation Analysis]